Parallel Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-200
Closed -$2.9K 3649
2025
Q1
$2.9K Sell
200
-25
-11% -$355 ﹤0.01% 2867
2024
Q4
$2.95K Buy
225
+127
+130% +$1.75K ﹤0.01% 2832
2024
Q3
$1.14K Buy
98
+25
+34% +$236 ﹤0.01% 3004
2024
Q2
$551 Sell
73
-30
-29% -$248 ﹤0.01% 3081
2024
Q1
$1.03K Sell
103
-36
-26% -$335 ﹤0.01% 2927
2023
Q4
$1.29K Sell
139
-363
-72% -$3.75K ﹤0.01% 2890
2023
Q3
$6.38K Sell
502
-2
-0.4% -$27 ﹤0.01% 2406
2023
Q2
$7.16K Sell
504
-849
-63% -$11.9K ﹤0.01% 2304
2023
Q1
$20.2K Buy
1,353
+849
+168% +$12.9K ﹤0.01% 1829
2022
Q4
$7.49K Hold
504
﹤0.01% 2154
2022
Q3
$8K Hold
504
﹤0.01% 2090
2022
Q2
$11K Sell
504
-24
-5% -$490 ﹤0.01% 1935
2022
Q1
$12K Buy
528
+24
+5% +$587 ﹤0.01% 1928
2021
Q4
$14K Hold
504
﹤0.01% 1966
2021
Q3
$14K Hold
504
﹤0.01% 1913
2021
Q2
$15K Hold
504
﹤0.01% 1828
2021
Q1
$13K Sell
504
-50
-9% -$1.28K ﹤0.01% 1804
2020
Q4
$14K Sell
554
-43
-7% -$807 ﹤0.01% 1646
2020
Q3
$10K Hold
597
﹤0.01% 1741
2020
Q2
$10K Sell
597
-125
-17% -$1.85K ﹤0.01% 1722
2020
Q1
$8K Sell
722
-2,348
-76% -$48.4K ﹤0.01% 1715
2019
Q4
$85K Buy
3,070
+1,077
+54% +$27K 0.01% 846
2019
Q3
$45K Buy
1,993
+876
+78% +$20K ﹤0.01% 1029
2019
Q2
$28K Buy
1,117
+335
+43% +$9K ﹤0.01% 1124
2019
Q1
$21K Buy
782
+431
+123% +$14.5K ﹤0.01% 1193
2018
Q4
$11K Buy
351
+89
+34% +$3.58K ﹤0.01% 1293
2018
Q3
$12K Hold
262
﹤0.01% 1367
2018
Q2
$11K Buy
262
+27
+11% +$1.29K ﹤0.01% 1308
2018
Q1
$13K Sell
235
-104
-31% -$5.7K ﹤0.01% 1174
2017
Q4
$18K Hold
339
﹤0.01% 1056
2017
Q3
$15K Buy
339
+47
+16% +$2.23K ﹤0.01% 1114
2017
Q2
$14K Sell
292
-20
-6% -$1.19K ﹤0.01% 1160
2017
Q1
$19K Sell
312
-77
-20% -$5.35K ﹤0.01% 980
2016
Q4
$26K Buy
+389
New +$25.3K 0.01% 771

Other funds holding MD

Parallel Advisors's MD Position: Q2 2025 in Review

Parallel Advisors sold out of Pediatrix Medical (MD) in Q2 2025, closing a stake of 200 shares — an estimated $2.9K sold.

Parallel Advisors first reported a position in MD in Q4 2016 and held it in 34 quarters. The position peaked at $85K in Q4 2019. 264 funds tracked by Wall St. Rank hold MD as of Q2 2025.

  • Parallel Advisors reported no remaining Pediatrix Medical position as of Q2 2025 after selling out during the quarter.
  • Parallel Advisors sold 200 Pediatrix Medical shares in Q2 2025, an estimated $2.9K.
  • Parallel Advisors first reported a position in Pediatrix Medical in Q4 2016 and held it in 34 quarters.
  • Parallel Advisors's Pediatrix Medical position peaked at $85K in Q4 2019.
  • 264 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.